Antigen-Specific In Vivo Killing Assay

Nada Chaoul1, Gilles Dadaglio2

  • 1Department of Emergency and Organ Transplant, School and Chair of Allergology and Clinical Immunology, University of Bari-Aldo Moro, Bari, Italy. nada.chaoul@uniba.it.

Summary

This study details an in vivo killing assay to measure the antigen-specific killing capacity of Cytotoxic CD8+ T Lymphocytes (CTLs). The protocol quantifies CTL lysis of cells presenting the SIINFEKL peptide from the OVA protein.

Related Concept Videos